This is a prospective, acceptability study to evaluate the gastrointestinal tolerance and compliance of a thickener for the management of reflux, GORD and dysphagia
To evaluate the gastrointestinal tolerance and compliance of a thickener for 7 days for the submission to the Advisory Committee for Borderline Substances (ACBS).
Study Type
OBSERVATIONAL
Enrollment
21
Each infant and child will be switch over to receive for a period of 7 days (new thickener)
Chelsea and Westminster Hospital Foundation Trust
London, United Kingdom
Gastrointestinal tolerance
Measure using daily diary
Time frame: 7 days
Participant compliance
Daily intake using diary
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.